A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

Clinical trial NCT00299026 · COMPLETED

Trial details

NCT number: NCT00299026
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2001-06-01
Primary completion: 2003-05-01
Enrollment: 532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.